Organization: Health Canada
Year: 2024
Month: May
Request Number: A-2023-001527
Request Summary: As of December 15, 2023, there are now two liraglutide submissions which appear on the Generic Submissions Under Review (GSUR) List. Provide the name of the company who submitted the Abbreviated New Drug Submission (ANDS); and the year and month in which the ANDS was accepted for review.
Disposition: Disclosed in part
Number of pages: 1